Automated ultrasound system for spinal landmark identification
Official title: Development of an Ultrasound Guided Automated Spinal Landmark Identification System (uSINE Study)
Run by KK Women's and Children's Hospital · NCT03687411 · Data updated 2026-11-12
This study is testing a new ultrasound system to help doctors find the right spots on the spine for needle insertion, aiming to make the process safer and more accurate for patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 75 Years |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | KK Women's and Children's Hospital Government |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | May 24, 2018 |
| Main results expected | October 14, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | August 7, 2026 |
| Trial ID | NCT03687411 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients aged 21-75 requiring neuraxial anesthesia, with specific inclusion criteria based on body mass index.
✕Probably not a fit
Patients with a history of scoliosis, spinal instrumentation, or drug allergies to ultrasound gel may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to develop and evaluate an ultrasound guided automated spinal landmark identification system (uSINE) to enhance the accuracy and safety of neuraxial needle insertion. The approach involves using real-time ultrasound imaging to identify spinal landmarks, which is expected to reduce the number of failed attempts and complications associated with traditional palpation techniques. The study will recruit 20 subjects, including both non-obese and obese patients, to assess the efficacy of this innovative technology in a prospective cohort design. The system will provide guidance to anesthetists during the procedure, potentially improving patient outcomes.
Why it matters
Potential benefit: If successful, this system could significantly improve the success rate of neuraxial procedures and reduce patient discomfort and complications.
How similar studies have gone: Previous studies have shown the effectiveness of ultrasound imaging in improving spinal anesthesia techniques, but this specific automated approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: First phase: * Age 21 - 75 years old patients who require neuraxial anesthesia for surgical procedure; * Normal body mass index (Weight 40-90 kg, Height 140-180cm). Second-fourth phases: * Obese patients aged between 21-75 years old; * body mass index more than 30. Exclusion Criteria: * History of scoliosis; * History of spinal instrumentation; * Drug allergy to ultrasound transmission gel; * Visible wound or injury in the lumbar spine.
Where it's running
-
KK Women's and Children's Hospital
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Ban L Sng, FANZCA — KK Women's and Children's Hospital
- Study coordinator: Ban L Sng, FANZCA
- Email: sng.ban.leong@singhealth.com.sg
- Phone: +6563941081
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ocular Changes in People Using Tirzepatide or Semaglutide
This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Berobenatide for knee pain in adults who are overweight or with obesity
This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists
This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.
-
EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes
This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.